Tata Capital To Pump In $4 Million Into Briton

The Indian pharma companies have been struggling to keep themselves afloat in the US market as USFDA is tightening the noose and laying stricter rules which are further threatening the export revenue based revenue of the several pharma giants. 

Amidst of this adverse climate, the Indian pharma companies are expanding constantly. The Bangalore-based Brinton Pharmaceuticals that provides healthcare products of various therapeutic segments has fetched Rs 25.6 crore from Tata Capital Healthcare Fund, reported a leading business daily. the company is on an expansion mode and they are planning to foray into the paediatrics and gynaecology and will also strengthen its overseas footprint in the years to come, revealed the report.

The business daily quoted Rahul Darda, managing director of Brinton Pharma saying, "Our plan is to enter into paediatric and gynaecology (segments). The funding will be used to enter these two areas. We will be adding 200 people for our paediatric section." 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717 
Share on Google Plus Share on Pinterest

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.